0 % CO2 in air, and ATP increased the secretion of surfactant compared with the controls. The stimulated secretion was inhibited by staurosporine, a protein kinase C inhibitor. DAG and PI contents of control cells were 50 + 1.1 (means+S.E.M., n = 8) and 14+0.8 nmol/mg phospholipid (n = 7) respectively. The DAG content increased by -50 nmol (100 %) within 5 s of treatment with both alkalosis and ATP, returned to control levels by 1 min, and increased again at 5 min by 20 nmol. The PI content decreased maximally by -6 nmol
INTRODUCTION
The lung surfactant phosphatidylcholine (PC) is stored in the lamellar bodies of alveolar type II cells before its secretion into the alveolar lumen. Among various mechanisms suggested for regulation of lung surfactant secretion, protein kinase C (PKC) activation has been postulated to contribute significantly [1] [2] [3] [4] [5] [6] . Our previous studies also showed a role for PKC in the stimulation of surfactant secretion by alkalosis, caused by lowering of CO2 concentration in the ventilation or incubation gas mixture [1, 2] .
1,2-Diacylglycerol (DAG) is the intracellular messenger for activation of PKC in a wide variety of cells. In type II cells, hydrolysis of (poly)phosphoinositides is stimulated by ATP [4, 6, 7] , and the concomitant increase in labelling of DAG and inositol phosphates suggests activation of phospholipase C (PLC). DAG, an activator of PKC, can also be formed by PLCdependent hydrolysis of PC or phosphatidylethanolamine (PE), or by phospholipase D (PLD)-dependent hydrolysis of PC and subsequent hydrolysis of phosphatidic acid thus formed by phosphatidate phosphatase [8, 9] . During our investigations on regulation of lung surfactant secretion, we observed that the alkalosis-and ATP-stimulated surfactant secretion from type II cells is inhibited by the PKC inhibitor staurosporine. Since analysis of changes in PI and DAG also supports that multiple metabolic sources (and pathways) are utilized for DAG increase with both alkalosis and ATP. Some of this work was previously presented in abstract form [2, 10] . [11] . In brief, lungs were cleared of blood by perfusion with solution I (2.6 mM phosphate buffer, pH 7.4, 10 mM Hepes, pH 7.4, 155 mM NaCl, 10 [12] , and the radioactivity in the lipid extract was measured. The aqueous phases from lipid extracts from cells and the medium were pooled, freeze-dried, and reconstituted in 10 ,ul of aq. 100 mM choline and 50 mM phosphocholine. A portion (3 ,ul) was then used for separation ofcholine and phosphocholine by t.l.c. on silica-gel G plates that were developed in 0.5 % NaCl/methanol/NH3 (50:50: 1, by vol.) [13] . Choline and phosphocholine on t.l.c. plates were revealed after exposure to 12 vapour, scraped off, and counted for 3H label in a scintillation counter. The radioactivity in each metabolite was then expressed as a percentage of total 3H label in the cells and the medium.
MATERIALS AND METHODS
Materials [methyl-3H]Choline, [y-32P]ATP, dipalmitoyl phosphatidyl- [methyl-14C]choline, D-myo-[2-3H]inositol, D-myo-[2-3H]inositol 1-phosphate (potassium salt), D-myo-[2-3H]inositol 1
Formation of Inositol phosphates
Cells (5 x 106/2.5 ml) were incubated with 7 ,uCi/ml [3H]inositol (sp. radioactivity 10-20 Ci/mmol) for 20-22 h to label cellular PI, and then washed five times with MEM and three times with the incubation buffer. The cells were then equilibrated for 30 min in 2 ml of incubation buffer containing 20 mM LiCl and 10 mM sodium orthovanadate and 5 % CO2 in air. At the end of this equilibration period, some culture dishes were incubated for various periods of time in the absence or presence of 1 mM ATP, or after transfer to 0 % CO2 (alkalosis). Individual incubations were terminated by rapid aspiration of the medium and addition of 2 ml of ice-cold methanol. After 15 min, the cells were scraped off and the steps repeated, and the pooled samples were extracted for lipids [12] . The upper aqueous phase from the lipid-extraction procedure was used to measure water-soluble inositol phosphates, and the lower organic phase was used to determine DAG and PI. Because of the brief periods of incubation, the incubations were staggered so that only one culture dish was handled at any time. The incubation medium did not contain LiCl and orthovanadate in experiments where only PI and DAG were measured. In some experiments, 100 nM staurosporine (10 #1 was added from a stock solution of 200 uM in dimethylformamide, which had been diluted with incubation buffer without bicarbonate to 10,uM) was present during the equilibration and subsequent incubation periods.
Inositol phosphates were separated by anion-exchange chromatography on AG1-X8 (formate form) after neutralization of a sample of the upper phase with KOH [14] . Briefly, after loading of the sample, free inositol was eluted with water (15 ml), glycerophosphoinositol with 5 mM sodium tetraborate/60 mM sodium formate (15 ml), inositol 1-phosphate (IP1) with 200 mM ammonium formate/100 mM formic acid (15 ml), inositol bisphosphate (IP2) with 400 mM ammonium formate/100 mM formic acid (15 ml), and inositol trisphosphate (IP3) with 1 M ammonium formate/100 mM formic acid (15 ml). Radioactive standards for IP1, IP2 and IP3 were run through the column to verify separation of individual inositol phosphates by using the protocol described above. Phospholipid P was measured by the method of Marinetti [18] as described previously [19] . P was assumed to comprise 4 % of the total mass of phospholipids. Results were first evaluated for differences by one-way or two-way analysis of variance and then analysed statistically by using the paired (within a cell preparation) or unpaired Student's t test. The statistical significance was accepted at P < 0.05.
RESULTS
Both ATP and alkalosis stimulated the secretion of surfactant PC from type II cells. During a 2 h incubation, PC secretion in cells exposed to alkalosis increased by -200 %, and in those exposed to 1 mM ATP increased by almost 4000% (Table 1) (n = 4, P < 0.05). In the presence of 100 nM staurosporine, the increase in PC secretion was only 20 % with alkalosis (P > 0.05 versus control) and 150 % with ATP (P < 0.05 versus control or ATP without inhibitor). A partial inhibition of ATP-stimulated secretion is compatible with activation of multiple pathways of signal transduction by ATP [3] .
Previous reports have suggested that ATP-and alkalosisstimulated secretion is mediated via activation of PKC [1, 4] (Figure 3) . The changes at 15, 30, 60 and 300 s represented increases of 450, 280, 280 and 370 %, respectively, above basal values. ATP also increased the formation of IP, and IP2 at all the time points except at 30 min. The increases in IP1 and IP2 were around 150 % and 500 % respectively at every time point except at 30 min. In contrast, alkalosis failed to enhance the formation of any of inositol phosphates at all time points investigated (Figure 3) . Thus, our studies suggest that ATP, but not alkalosis, stimulates (poly)polyphosphoinositide-specific phospholipase C in type II cells.
We also investigated the effect of ATP and alkalosis on the PI content oftype II cells. The basal level ofPI was 14 + 0.8 nmol/mg of phospholipid (n = 7). A time course of changes in the mass of PI with ATP and alkalosis is shown in Figure 4 . Our earliest observation was at 5 s, at which time the PI content showed a maximal decrease of -40% with either ATP or alkalosis. Thereafter, the PI content returned towards the control level by 30 s and was unchanged thereafter up to 30 min. Since the PI decrease parallels the DAG increase, a portion of DAG can come from PI hydrolysis.
Determination of PI and DAG contents enabled us to carry out mass-balance analysis of changes in these two lipids in secretagogue-stimulated type II cells (Table 2 ). After 5 s of treatment, compared with corresponding controls, the DAG content was higher by 50 nmol/mg of total phospholipid with ATP, and by 40 nmol/mg of total phospholipid with alkalosis. In comparison, the PI content decreased by about 6-7 nmol/mg of phospholipid with both ATP and alkalosis. Thus only about 100% of the change in DAG could be accounted for by PI hydrolysis.
PKC plays a regulatory role in DAG formation by inducing PC hydrolysis [20] , or inhibition of PLC-catalysed phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis [26] . To investigate whether PKC played any role in DAG increase, we evaluated the effect of staurosporine on the early increase in DAG content with alkalosis and ATP. We anticipated that staurosporine inhibition of PKC would alter the secretagogueinduced increase in the DAG content. In four separate experiments, the DAG content of control cells was 48+6 and 43 + 8 nmol/mg of phospholipid respectively in the absence or presence of 100 nM staurosporine which was added at the start of equilibration period of 30 min. Under these conditions, a 30 s treatment with alkalosis and ATP increased the DAG content to 70+6 (P < 0.05) and 66+10 (P < 0.05) nmol/mg respectively in the absence of staurosporine. In cells pretreated with staurosporine, the DAG content increased to 63 + 7 and 60 + 4 (P < 0.05 versus control) nmol/mg with alkalosis and ATP respectively. Thus [4, 6, 7] . However, labelling protocols determine only relative changes in DAG [7, 20] , since all of the metabolic lipid pools may not be labelled to the same specific radioactivity, and therefore may not accurately represent their mass distribution [27] . Therefore it is important to establish whether any of these agents induce changes in DAG content.
The [15] . This difference is possibly reflected in the observation that the stimulus-induced change in PI is greater than that in DAG of tracheal preparations [15] . In type II cells, their relative contents and the changes in PI and DAG contents showed a reverse order.
Our findings on the initial phases of changes in DAG and PI contents suggest a direct relationship between these two lipids ( Figures 1 and 4) , and are in agreement with previous reports employing metabolic labelling-kinetics protocols [7, 8] . However, our mass-balance analysis indicates that only a small amount (-10 %) of DAG increase may arise from PI, and that a large proportion of the early increase is derived from other sources ( Table 2 ). This analysis also suggests that the hydrolysis of all the cell PI, the precursor for (poly)phosphoinositides, cannot fully account for the total increase in DAG. Our calculations do not take into account the metabolic utilization of DAG via DAG kinase or DAG lipase, as previously demonstrated in human platelets [28, 29] . Activation of these two enzymes for the removal of DAG will only underestimate the DAG increase. That the DAG levels were higher at later time points, and the PI content was unchanged (Figures 1 and 4) , also implies utilization of other phospholipids for the DAG increase. Other investigators also drew similar conclusions from mass-balance analysis of stimulusinduced changes in IP3 and DAG in Swiss 3T3 cells [23] .
Our studies on PC hydrolysis support activation of PLC by alkalosis, and of both PLC and PLD by ATP, to form phosphocholine and choline. The labelling profiles for choline and phosphocholine permit calculation of the relative contributions of PLC-and PLD-catalysed hydrolysis of PC. Assuming that PC is labelled to equilibrium, any changes in the labelling of phosphocholine and choline suggest quantitative hydrolysis of PC via PLC-and PLD-catalysed reactions. Our assumption is also supported by the fact that the ratio of label recovered in choline and phosphocholine (0.6 % and 5.5 % respectively) in control cells is similar to the ratio of their pool sizes previously reported in type II cells or lungs [30, 31] . We suggest that PC hydrolysis via PLD is unlikely to contribute significantly to the DAG pool. This is based on the observations that the labelling of choline was unaltered with alkalosis, and was increased only after 50 s with ATP. Also, the increased labelling of choline with ATP represented hydrolysis of about 0.4 % ofcell PC. This is similar to ATP-stimulated PLD-mediated phosphatidylethanol formation in type II cells labelled with acetate [22] . In comparison, a rapid increase in the labelling of phosphocholine demonstrates that each agonist stimulates PLCcatalysed hydrolysis of PC, which can contribute almost half of the DAG increase. Although various investigators have suggested that both PLC-and PLD-catalysed hydrolysis of PC contributes that only PLC-dependent breakdown of cellular PC in type II cells contributes significantly. On the basis of the rapid labelling of phosphocholine, we further suggest that the plasma-membrane PC is the preferred substrate. Previous studies have shown that agonists (ATP) increase PLC-mediated hydrolysis of PC in rat liver plasma membrane [24] .
The underlying mechanisms for the biphasic increase in DAG are not known, but may be related to the presence of multiple substrates. Other investigators also observed a biphasic increase in DAG content in bombesin-stimulated Swiss 3T3 fibroblasts and suggested that DAG may be derived from PC [23] . It has been suggested that PIP2 hydrolysis may provide the first increase and serve to initiate DAG generation from an alternative source, probably PC or PE [8, 9, 23, 24, 32, 35] . This is supported by the observations that the molecular-species profile of DAG in thrombin-stimulated fibroblasts resembles both PI and PE profiles at early time points and the PC profile at later time points [36] . However, it is unlikely that PIP2 hydrolysis is required for the second increase in DAG in type II cells. First, alkalosis did not increase IP3 formation, but caused a biphasic increase in DAG (Figures 1 and 3) , and second, there was no secondary increase in phosphocholine or choline label (Figure 2 ) to suggest PC hydrolysis at another intracellular site. A likely explanation for the second DAG peak is that other phospholipids, possibly PE, are mobilized.
In contrast with their similar effects on DAG and PI contents, the effects of ATP and alkalosis on the formation of inositol phosphates and choline ( Figure 3) were different. In agreement with previous investigators [6, 7, 20, 22] , we also observed that ATP increased the PLC-specific hydrolysis of (poly)-phosphoinositides and PLC-and PLD-specific hydrolysis of PC. However, the mechanism by which PI breakdown is increased with alkalosis is unknown. Since we did not observe accumulation of inositol phosphates, we suggest that alkalosis activates Plspecific PLD, which would increase PI hydrolysis to form phosphatidic acid and inositol, and has been previously characterized in human neutrophils [37] . Since PKC activation stimulates PLD-catalysed hydrolysis of phospholipids [20, 22] , and ATP, but not alkalosis, increased choline formation ( Figure  2 ), there may also be differences in the type of PKC activated by each of these agonists.
PKC modulates phospholipid hydrolysis in a dual manner. In type II cells, phorbol 12-myristrate 13-acetate (a direct activator of PKC) activates PC hydrolysis [20] , suggesting a positive co-operativity between PKC activation and DAG generation. In mesangial cells, angiotensin-and vasopressin-induced and PLC-activated hydrolysis of (poly)phosphoinositides can be attenuated by short-term activation of PKC [38, 39] , suggesting a feedback inhibition of PLC (and DAG generation) by PKC. Since DAG content was unchanged in staurosporine-treated cells, we suggest that PKC does not contribute significantly to the DAG increase by mechanisms discussed above. However, staurosporine inhibition of surfactant secretion supports a role for PKC that may be activated after the DAG increase.
In conclusion, we have demonstrated that ATP and alkalosis stimulate the hydrolysis of PC and (poly)phosphoinositides, and increase the DAG content and surfactant secretion in type II cells. We suggest that PLC-catalysed PC hydrolysis contributes significantly to the increase in DAG content, whereas a smaller proportion may be derived from (poly)phosphoinositide hydrolysis. The enzymic pathways catalysing hydrolysis of (poly)-phosphoinositides appear to be different in ATP and alkalosis. The physiological role for the biphasic increase and the relative importance of the two increases in DAG in the regulation of to the DAG increase [8, 21, 24, [32] [33] [34] ], our results demonstrate surfactant secretion remain to be determined.
